Stevens Johnson Syndrome and Toxic Epidermal Necrolysis skin disorder lawsuit investigation 2023: Is It a Scam? Find Out!

Did you develop a severe rash known as Stevens Johnson Syndrome after taking a new medication? Did you receive a mail about a class action on the settlement to resolve claims about the Stevens Johnson Syndrome lawsuit? This review will help you partake in the class action settlement after confirming the authenticity of the mail.

What Is Stevens Johnson Syndrome and Toxic Epidermal Necrolysis skin disorder Class Action Settlement?

Stevens Johnson Syndrome, or SJS, is an allergic reaction to a drug that attacks the skin and mucous membranes. Stevens Johnson Syndrome results in blisters and skin burns that cover less than 10% of the body’s surface area.

Toxic Epidermal Necrolysis (TEN) is a more severe form of SJS. The body surface area it covers extends beyond 30%.

SJS–TEN overlap impacts between 10%–30% of the total body surface area (TBSA).

Nearly all cases of Stevens Johnson syndrome are induced by a drug. TEN is always caused by a pharmaceutical drug product.

What Is This Class Action All About?

Hundreds of new diagnoses of SJS are reported every year. Plaintiffs in SJS and TEN lawsuits cite numerous symptoms and complications caused by taking over-the-counter pain relievers, antibiotics, anti-seizure medications, anti-gout medications, and many more.

There are several early signs of Stevens Johnson Syndrome to look out for. SJS begins with flu-like symptoms and a rash and can lead to blistering, severe peeling, open sores, and can result in death.

The death rate from TEN has been reported to be between 30%-80%, which is why it’s imperative that patients are closely monitored under the supervision of hospital staff. SJS and TEN can result in permanent injuries. In those cases where the injured consumer does recover, the recovery process can take weeks to months, depending on the severity of the situation, which can rack up thousands of dollars in medical bills.

An SJS lawsuit is often the only way patients can recover money from the drug maker for inadequately warning them about the risk of SJS.

TEN (also known as “Lyell’s syndrome”) is a rare, life-threatening skin condition that causes large sheets of skin to detach from the body, as well as lesions in the mucous membranes, such as the mouth, eyes, and vagina.

TEN symptoms are often preceded by fever, followed by a rash over large parts of the body. The top layer of the skin fills with fluid deposited by the body’s immune system, which then begins to sag from the body and can be peeled off in large sheets, leaving the patient vulnerable to infections that can result in sepsis. SJS and TEN can also cause mouth blisters that make eating difficult, as well as eye problems such as swelling, crusting, ulcers, and blindness.

Possible TEN and SJS complications include:

  • Secondary skin infection (cellulitis);
  • Sepsis (blood infection);
  • Eye problems that can lead to blindness;
  • Internal organ damage;
  • Permanent skin damage; and
  • Death

Attorneys are actively investigating cases of SJS and TEN against drug manufacturers for failing to warn medication users and their physicians about these life-threatening diseases. Many drugs associated with SJS and TEN have inadequate warnings on the product labels, and the drug manufacturers should be held liable.

Who Is Eligible?

The settlement benefits all class members who were diagnosed with SJS or TEN caused by an allergic drug reaction in the last three years.

How To Be Part of This Settlement

For a class member to partake in this settlement, they must submit their Valid claim on the settlement website.

What Is The Pay For This Settlement?

The pay for this settlement varies and the proof of purchase is not necessary.

Conclusion

As you submit your claim to the settlement website, just like Traumatic Brain Injury class action settlement we have reviewed , you’re doing so under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim.

Leave a Comment

error: Content is protected !!